Etonogestrel
Who holds supplier records for Etonogestrel? 6 organisations hold a current record for Etonogestrel: an active US FDA Type II Drug Master File or a CEP. 3 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (3), Netherlands (1), Spain (1) and Hungary (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Etonogestrel: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/etonogestrel
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Etonogestrel expires 28 Jul 2030. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Etonogestrel. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ASPEN OSS BVNetherlandsCEP Company GMP cert on recordActive DMF 12293 · latest filing Dec 1996
- CURIA SPAIN SAUSpainCEP Company GMP cert on recordActive DMF 32271 · latest filing Dec 2017
- INDUSTRIALE CHIMICA SRLItalyCEP Company GMP cert on recordActive DMF 29165 · latest filing Apr 2015
- Gedeon RichterHungary Company GMP cert on recordActive DMF 11997 · latest filing Jun 1996
- STERLING SPAItaly Company GMP cert on recordActive DMF 24651 · latest filing Feb 2011
- STEROID SPAItaly Company GMP cert on recordActive DMF 39455 · latest filing Feb 2024
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (3)
Certificates of Suitability on the EDQM register for Etonogestrel, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ASPEN OSS B.V. Oss | NL | CEP 2024-341 - Rev 00 Etonogestrel, Micronised and non-micronised | Feb 2026 | Inspected Oct 2025 Netherlands |
| INDUSTRIALE CHIMICA S.R.L. Saronno | IT | CEP 2025-195 - Rev 00 Etonogestrel | Nov 2025 | Inspected Oct 2025 Italy |
| CURIA SPAIN S.A.U. Boecillo | ES | CEP 2025-093 - Rev 01 Etonogestrel | Oct 2025 | Inspected Feb 2026 Spain |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (1 listed product contain Etonogestrel). The latest listed patent expires 28 Jul 2030. The latest listed exclusivity runs to 16 Jan 2029. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Etonogestrel is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1531).
Chemical identity
- IUPAC name
- (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
- Canonical SMILES
- CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34
- InChIKey
- GCKFUYQCUCGESZ-BPIQYHPVSA-N
- Synonyms
- Desogestrel related compound c, Etonogestrel, Etonogestrel component of nuvaring, Implanon, Nexplanon, ORG 3236, ORG-3236, 3-Oxodesogestrel, 3-Ketodesogestrel, 3-Keto-desogestrel, etonogestrelum, CHEBI:50777
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Progestin
- Chemical structure
- Progesterone Congeners
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Etonogestrel?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Etonogestrel: ASPEN OSS BV (Netherlands), CURIA SPAIN SAU (Spain), INDUSTRIALE CHIMICA SRL (Italy), Gedeon Richter (Hungary), STERLING SPA (Italy) and STEROID SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Etonogestrel Drug Master Files are active?
ASPEN OSS BV (DMF 12293), CURIA SPAIN SAU (DMF 32271), INDUSTRIALE CHIMICA SRL (DMF 29165), Gedeon Richter (DMF 11997), STERLING SPA (DMF 24651) and STEROID SPA (DMF 39455). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Etonogestrel have a European Certificate of Suitability?
Yes. 3 organisations hold a valid CEP for Etonogestrel on the EDQM register, including ASPEN OSS B.V. Oss (NL), INDUSTRIALE CHIMICA S.R.L. Saronno (IT) and CURIA SPAIN S.A.U. Boecillo (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Etonogestrel?
Yes. The latest patent listed for an approved US product containing Etonogestrel expires 28 Jul 2030, across 1 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Etonogestrel supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Etonogestrel?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.